SCHEMBL8004675

SCHEMBL8004675

Cn1c(-c2ccccn2)nc(-c2ccc(-c3nnco3)cc2)c1Sc1ccc(F)cc1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.42
NOTUM Q6P988 5/20 0.38
RAB9A P51151 7/20 0.37
NPC1 O15118 6/20 0.37
KDM4E B2RXH2 3/20 0.36
RXFP1 Q9HBX9 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
OPRK1 P41145 1/20 0.33
EDNRA P25101 1/20 0.32
CTSD P07339 1/20 0.32
GUSB P08236 1/20 0.32
FFAR1 O14842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8001939 0.88 FAAH (0.42) FAAHNOTUMRAB9ANPC1KDM4E
SCHEMBL8011114 0.87 FAAH (0.50) FAAHNOTUMRAB9ANPC1KDM4E
SCHEMBL8002857 0.85 FAAH (0.48) FAAHNOTUMRAB9ANPC1KDM4E
SCHEMBL8001993 0.82 FAAH (0.52) FAAHNOTUMRAB9ANPC1KDM4E
SCHEMBL8004010 0.80 FAAH (0.61) FAAHNOTUMRAB9ANPC1KDM4E
SCHEMBL12106397 0.79 FAAH (0.43) FAAHNOTUMRAB9ANPC1KDM4E
SCHEMBL12106423 0.79 FAAH (0.49) FAAHNOTUMRAB9ANPC1KDM4E
SCHEMBL12106766 0.79 FAAH (0.67) FAAHRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL8005530 0.79 FAAH (0.49) FAAHNOTUMRAB9ANPC1SMN1; SMN2
SCHEMBL8001937 0.78 FAAH (0.41) FAAHNOTUMRAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885NOTUM 397/4885RAB9A 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.